FDA Authorizes Updated Covid Vaccines For Kids as Young as 6 Months
December 08 2022 - 10:44AM
Dow Jones News
By Will Feuer
The U.S. Food and Drug Administration amended the emergency use
authorizations for Moderna Inc.'s and Pfizer Inc.'s updated
Covid-19 vaccines to authorize their use on children as young as
six months of age.
The new authorization means children between the ages of six
months and five years who received the original two-shot Moderna
Covid-19 vaccine series can now receive a booster shot of the
updated vaccine, which is tailored for defense against the latest
strains of the virus.
Children between the ages of six months and four years who have
not yet begun the three-dose series of the Pfizer vaccine, which is
made with BioNTech SE, or have not yet received the third dose can
now get the updated vaccine as the third dose of their series after
receiving two shots of the original Pfizer vaccine, the FDA
said.
Children between the ages of six months and four years who have
already completed the three-shot Pfizer series will not be eligible
for a booster dose of an updated bivalent vaccine, the FDA
said.
"As this virus has changed, and immunity from previous Covid-19
vaccination wanes, the more people who keep up to date on Covid-19
vaccinations, the more benefit there will be for individuals,
families and public health by helping prevent severe illnesses,
hospitalizations, and deaths," FDA Commissioner Robert Califf
said.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
December 08, 2022 10:29 ET (15:29 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Sep 2023 to Sep 2024